¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°£¾ÏÇÐȸ Á¦17Â÷ Á¤±âÇмú´ëȸ-Beating HCC Together : 2023-03-17

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ°£¾ÏÇÐȸ Á¦17Â÷ Á¤±âÇмú´ëȸ-Beating HCC Together : 2023-03-17
±³À°ÀÏÀÚ : 2023-03-17
±³À°Àå¼Ò : ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë  
±³À°ÁÖÁ¦ : (¿ÀÇÁ¶óÀÎ) ´ëÇÑ°£¾ÏÇÐȸ Á¦17Â÷ Á¤±âÇмú´ëȸ-Beating HCC Together
ÁÖÃÖ±â°ü : ´ëÇÑ°£¾ÏÇÐȸ
´ã´çÀÚ : ÀÌÁøÈ­ Â÷Àå
¿¬¶ôó : 02-373-1005  
À̸ÞÀÏ : klca@hbni.co.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú      
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 10 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 60,000¿ø      
ºñ°í »çÀüµî·Ï : Æò»ýȸ¿øÁ¤È¸¿ø-4¸¸¿ø, ºñȸ¿ø-5¸¸¿ø, ÀüÀÓÀÇÀü°øÀDZºÀÇ°ü°£È£»ç-2¸¸¿øÇöÀåµî·Ï : Æò»ýȸ¿øÁ¤È¸¿ø-5¸¸¿ø, ºñȸ¿ø-6¸¸¿ø, ÀüÀÓÀÇÀü°øÀDZºÀÇ°ü°£È£»ç-3¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 08:45~09:00 Noncontrast MRI with Diffusion-Weighted Imaging for Detecting HCC  À̵¿È£(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 09:00~09:15 Tissue Acquisition for the Accurate Diagnosis of HCC: Surgeon  ÀÌÀç±Ù(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 09:15~09:30 Digitial Pathology and AI for the Diagnosis of HCC  À̼ºÇÐ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 09:30~09:45 Novel Biomarkers for Early Diagnosis of HCC  Á¤½Â¿ø(¼øõÇâÀÇ´ë) 
È޽Ġ03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 09:45~09:55 Coffee Break  .(.) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 09:55~10:25 Early Mechanism of Liver Carcinogenesis  Jessica Zucman-Rossi(ILCA) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 10:25~10:45 Challenges and Opportunities of Combining Immunotherapy with Locoregional Therapies  Bruno Sangro(ILCA) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 10:45~11:05 Comparison of Locoregional and Systemic Treatment in Eastern and Western Guidelines  Joong-Won Park(KLCA) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 11:05~11:25 Stratification for Systemic Therapy – Are We Making Progress?  Tim Meyer (ILCA)(ILCA) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 11:25~11:45 Image Guided Ablation of Early HCC: Up to Date  Jeong Min Lee (KLCA)(KLCA) 
±âŸ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 11:45~12:45 Lunch Break & °¨»çÆÐ Àü´Þ½Ä ¹× ±¹¾Ç°ø¿¬  .(.) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 12:45~13:25 2023 KLCA Practical Guidance of TACE: Expert Consensus  ÀÌÀÎÁØ(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 13:25~13:55 Strategical Application of Radiotherapy for Advanced HCC in the Immunotherapy Era  ¼ºÁø½Ç(¿¬¼¼ÀÇ´ë) 
È޽Ġ03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 13:55~14:05 Coffee Break  .(.) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 14:05~14:20 Various Ablation Techniques for Treatment of HCC  À̹οì(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 14:20~14:35 Extended Application of TAREs and Interventional Therapies for Intermediate HCC  À̺´Âù(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 14:35~14:50 Recent Advances of Surgical Resection and LT  ¹®´öº¹(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 14:50~15:05 New Technologies of Radiotherapy on HCC Treatment  ¹ÚÈñö(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 15:05~15:20 Immune-Based Therapies for HCC  ÀÌÁ¤ÈÆ(¼­¿ïÀÇ´ë) 
±âŸ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 15:20~16:20 Poster Presentation  .(.) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 16:20~16:35 Advanced AI in the Prediction of Clinical Outcomes of HCC  ÀÓ¼±¿µ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 16:35~16:50 Biomarker-Based Prediction of Clinical Outcomes in HCC  ¼ºÇʼö(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 16:50~17:05 Updates of Imaging Features Related with Prognosis of HCC  ¼ÛÁö¼ö(ÀüºÏÀÇ´ë) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 17:05~17:20 Pathological Classification for Predicting HCC Prognosis  ÀÌÇý¿ø(°è¸íÀÇ´ë) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 08:45~09:05 °£¾Ï¿¡¼­ 2Â÷ Ç×¾ÏÄ¡·áÀÇ ±Þ¿©±âÁØ °³¼±  ÀÌÇѾÆ(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 09:05~09:30 º¸ÇèÀǾàÇ° °ü¸®Á¦µµ: ºñ¿ë-È¿°úºÐ¼®À» Áß½ÉÀ¸·Î  ÀÌÇѱæ(¾ÆÁÖ´ë) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 09:30~09:55 Ç×¾ÏÁ¦ ±Þ¿© µîÀç¿Í ±Þ¿© ±âÁØ  ÀåÁØÈ£(°Ç°­º¸Çè½É»çÆò°¡¿ø) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 14:05~14:20 Indication of Hepatic Resection: Hepatologist View  Á¶ÁÖ¿¬(Á¶¼±ÀÇ´ë) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 14:20~14:40 Expanded Indication for Hepatic Resection  ÃÖ¿µ·Ï(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 14:40~15:00 Peri-op Considerations after Transarterial or Locoregional Therapy  ¹Ú¿µ¸ñ(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 15:00~15:20 »õ·Î¿î ¼ö¼ú ±â¹ý¿¡ ´ëÇÑ ¼Ò°³: 3D Reconstruction, ICG Fluorescent Image  ±èÁöÈÆ(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 15:20~15:35 °£¾Ï ¼ö¼ú ÈÄ °£È£°ü¸®  À±Áö¼±(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 15:35~15:50 TACE ¹× RFA µî °£¾Ï ½Ã¼ú ÈÄ °£È£ °ü¸®  ¼±Á¦ÀÎ(¼­¿ï¼º¸ðº´¿ø) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 15:50~16:05 °£¾Ï ȯÀÚÀÇ ¿µ¾ç°ü¸®  ±èÈñ¾ð(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 16:05~16:20 °£¾Ï ȯÀÚÀÇ ÅëÁõ °ü¸®  À¯½ÅÇý(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 16:20~16:35 Pre-and Post Procedural Evaluation for Transarterial Therapy  Á¶¿µÀ±(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 16:35~16:55 Indication and Differences between TACE, DEB-TACE, and TARE  ±Ç·Á¹Î(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 16:55~17:05 Chemotherapeutic Agents in TACE  ÃÖÁø¿ì(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 03-17 ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 17:05~17:20 How to Choose the Best Modality for Transarterial Therapy – Case Based  Çöµ¿È£(¼º±Õ°üÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°£¾ÏÇÐȸ Á¦17Â÷ Á¤±âÇмú´ëȸ-Beating HCC Together : 2023-03-17""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼­¿ï¾Æ»êº´¿ø (¿Â¶óÀÎ) ÄÚ¼ö¼ú ÈÄ¿¡ ³ªÅ¸³¯ ¼ö ÀÖ´Â ´Ù¾çÇÑ ÇÕº´Áõ°ú ±×¿¡ ´ëÇÑ Ä¡·á : 2023-03-17
´ÙÀ½±Û ´ëÇÑÀçÈ°ÀÇÇÐȸ È£³²Á¦ÁÖÁöȸ 108Â÷ Çмú Áý´ãȸ : 2023-03-17
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
345 ÀüºÏ ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ ÀÎÁöÁßÀçÄ¡·áÀÇ ½ÇÁ¦¿Í Àü¸Á : 2018-09-04 0 538 2018-08-08
344 ºÎ»ê ºÎ¿ï°æ³»ºÐºñ´ë»çÇÐȸ 9¿ù Á¤±âÁý´ãȸ : 2018-09-04 0 482 2018-08-08
343 ¼­¿ï Á¦42ȸ ÇѸ²´ëÇб³°­³²¼º½Éº´¿ø ¾È°ú Áý´ãȸ : 2018-09-03 0 858 2018-08-08
342 ¼­¿ï ¼øõÇâ´ëÇм­¿ïº´¿ø Á¦42ȸ º¹ºÎÃÊÀ½ÆÄ ¹× ³»½Ã°æÃÊÀ½ÆÄ Áø´Ü ¿öÅ©¼ó : 2018-09-02 0 933 2018-08-08
341 ºÎ»ê Á¦21ȸ ´ëÇѳ»°úÇÐȸ ºÎ»ê°æ³²Áöȸ ¿¬¼ö°­Á : 2018-09-02 0 851 2018-08-08
340 ¼­¿ï 2018 ¼Ò¾Æ³»ºÐºñÇÐȸ ¿¬¼ö°­Á : 2018-09-02 0 1,186 2018-08-08
339 ´ëÀü ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ Á¦10ȸ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­±³À° (part4, 2ÀÏÂ÷) : 2018-09-02 0 590 2018-08-08
338 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø Á¦23ȸ ´ç´¢º´ÀÇ ¿À´Ã°ú ³»ÀÏ : 2018-09-02 0 1,401 2018-08-08
337 ¼­¿ï ´ëÇÑû°¢ÇÐȸ 2018 Á¦19Â÷ º¸Ã»±â¿öÅ©¼¥ : 2018-09-02 0 725 2018-08-08
336 ºÎ»ê 2018³â ´ëÇѹ̼¼¼ö¼úÇÐȸ Ãß°è Microsurgery Workshop : 2018-09-02 0 1,041 2018-08-08
335 ´ëÀü ´ëÇÑÀÓ»ó½Å°æ»ý¸®ÇÐȸ Á¦4ȸ ã¾Æ°¡´Â ¿öÅ©¼ó : 2018-09-02 0 1,005 2018-08-08
334 ´ë±¸ ´ë±¸±¤¿ª½ÃÀÇ»çȸ 2018 Á¾ÇÕÇмú´ëȸ : 2018-09-02 0 719 2018-08-08
333 ¼­¿ï 2018³â ´ëÇÑ¿Ü°úÀÇ»çȸ Ã߰迬¼ö°­Á : 2018-09-02 1 3,004 2018-08-08
332 ´ëÀü ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ Á¦10ȸ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­±³À° (part4,1ÀÏÂ÷) : 2018-09-01 0 426 2018-08-08
331 ´ëÀü ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ Á¦10ȸ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­±³À° (part4,1ÀÏÂ÷) : 2018-09-01 0 992 2018-08-08
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷